Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
24 authors.
Sarah van VeenLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. sarah.vanveen@kuleuven.be.ORCID 0000-0002-7639-7847
Emily MeeusLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.ORCID 0009-0004-9074-4296
Dolores IralaDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0001-5799-5342
Kristina SakersDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0001-8853-053X
Zhaolin LiuCenter for Pediatric Neurological Disease Research, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0001-6161-766X
Justin SavageAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.ORCID 0000-0002-1530-4942
Gabrielle SéjournéAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.ORCID 0000-0002-4633-2700
Dhanesh Sivadasan BinduDepartment of Cell Biology, Duke University Medical Center, Durham, NC, USA.ORCID 0000-0002-1545-1547
Elke AusloosLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Hanna Elzbieta GrzesikLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.ORCID 0009-0000-8647-3121
Hanne DhondtLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0002-5940-1920
Nina SchoonvlietLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Chris Van den HauteAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.ORCID 0000-0002-6650-3845
Joris Van AsselberghsAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.ORCID 0000-0002-6482-8718
Marta Montpeyó Garcia-MorenoAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.ORCID 0000-0002-9241-1047
Keimpe WierdaVIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium.ORCID 0000-0002-8784-9490
Veerle BaekelandtAligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.ORCID 0000-0001-8966-2921
Konrad PlatzerInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.ORCID 0000-0001-6127-6308
Kevin RostasyDepartment of Pediatric Neurology, Children's Hospital Datteln, University Witten/Herdecke, Datteln, Germany.ORCID 0000-0002-2180-5321
Kai Lee YapDepartment of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Jan EggermontLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0002-8497-1159
Matthew G HoltInstituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal.ORCID 0000-0002-8958-4027
Cagla Eroglu *Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.ORCID 0000-0002-7204-0218
Peter Vangheluwe *Laboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. peter.vangheluwe@kuleuven.be.ORCID 0000-0002-7822-2944
Funding
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Medical Scientist Training Program Training GrantT32GM145449 · NIGMS · DUKE UNIVERSITY · PI Christopher D Kontos · 2022 to 2026
Polyamines, such as spermidine, are essential regulators of brain development, yet how cells control their uptake and extracellular levels remains unclear. Here we show that ATP13A4, a transport protein enriched in glia and prominently expressed in astrocytes, governs brain polyamine balance. Using biochemical, cellular, and animal models, we find that ATP13A4 imports polyamines into cells and thereby limits their availability outside cells. Loss of ATP13A4 simplifies astrocyte morphology and increases the excitatory connections, or synapses, that astrocytes promote between neurons; adding spermidine reproduces these effects, identifying extracellular spermidine as a synapse-promoting signal. In mice lacking Atp13a4, brain polyamines are redistributed, with reduced levels in the cortex and accumulation in cerebrospinal fluid. This is accompanied by excess excitatory synapses, delayed early development, and mild, female-biased behavioral changes in adulthood. Rare ATP13A4 variants linked to neurodevelopmental disorders disrupt its function. Thus, astrocytic polyamine clearance via ATP13A4 tunes extracellular spermidine to shape synapse formation during development.
Indexed as
Membrane Transport ProteinsNeurogenesisPolyaminesSynapsesAnimalsAstrocytesBrainFemaleHumansMiceMice, KnockoutNeurodevelopmentNeuronsSpermidineMembrane Transport ProteinsPolyaminesSpermidine
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
ATP13A4 gates extracellular polyamine levels to control excitatory synaptogenesis. · full record | OpenQuestion